Denver Pharmaceutical Mfg. Co. v. Crystal Chemical Co.
This text of 230 A.D. 854 (Denver Pharmaceutical Mfg. Co. v. Crystal Chemical Co.) is published on Counsel Stack Legal Research, covering Appellate Division of the Supreme Court of the State of New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
Order denying defendant’s motion to vacate or modify notice of examination before trial reversed upon the law and the facts, without costs, and motion to modify granted, without costs, to the extent of striking from item 10 of the notice the words “ and the profit's therefrom; ” plaintiff, within five days from service of a copy of the order herein, to pay defendant the subpoena fees due to the witness Gillespie under subdivision 3, section 404 of the Civil Practice Act. Upon payment of such fees, examination to proceed on five days’ notice before the justice presiding at Special Term of the Supreme Court of the State of New York, in and for the county of Bronx, at the place and hour stated in the order. The plaintiff is not entitled to an examination as to the [855]*855profits at tMs stage of the case. (Conrady v. Buhre, 148 App. Div. 776; De Rapalie v. Gavin, 209 id. 883.) Lazansky, P. J., Kapper, Carswell, Seudder and Tompkins, JJ., concur.
Free access — add to your briefcase to read the full text and ask questions with AI
Related
Cite This Page — Counsel Stack
230 A.D. 854, Counsel Stack Legal Research, https://law.counselstack.com/opinion/denver-pharmaceutical-mfg-co-v-crystal-chemical-co-nyappdiv-1930.